Biocat

In a year made difficult by the pandemic, the life sciences and healthcare sector in Catalonia reached an exceptional milestone:€226 million in investment, the most ever in its history.

The call is now open for the program that allows companies to post their innovation challenges on an online platform and get proposals from academia and research.

Barcelona landscape

To answer this ambitious goal, we have developed the analysis 'The BioRegion of Catalonia: road to €500M in investment per year" which presents questions and answers about this possible ecosystem scaling.

Jobs Listing

The sector’s top place for job offers in Catalonia. 

BioRegion Directory

More than 1,000 companies and a wide network of universities, hospitals and research entities.

News

22.04.2021
The pandemic has shown that online pitches are here to stay. That’s why, in order to adapt to the sector’s new needs, the second Pitch Training Program will use a hybrid approach, with participants learning to defend...
15.04.2021
The call is now open to take part in the 4th edition of the Open Innovation Forum, the program promoted by Biocat, Bosch i Gimpera Foundation, UAB Research Park, CIT/UPC and UPF Ventures that gives companies the chance...
12.04.2021
Biocat has opened the call to take part in the 4th annual CRAASH Barcelona acceleration program, which helps researchers and entrepreneurs launch innovations in the healthtech arena to market, in collaboration with the...

Upcoming events

28.04.2021 to 30.04.2021
Lloc:

Digital Format

START-UP GENERATION
400x400.png
11.03.2021

Antoni Matilla is the founder of the spinoff Biointaxis as well as Director of the Neurogenetics Research Unit at the Institute for Health Science Research Germans Trias i Pujol (IGTP). He is a researcher, doctor and entrepreneur with over thirty years of experience in research and business management in Catalonia, United States and United Kingdom. Since 1990, his research has focused on understanding and curing hereditary ataxias, a group of minority hereditary neurodegenerative diseases that have no cure so far.